Investigating targeted therapy combinations in metastatic HR+ breast cancer Published 2023-05-19 Download video MP4 360p Recommendations 26:08 Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Year in Review Conference 1:03:23 Targeted Therapies Precision Medicine Approaches | 2023 Best of Breast Conference 11:20 How to Treat Metastatic Breast Cancer: All You Need to Know 02:06 Exploring novel therapeutic approaches in HR+/ HER2- mBC 03:10 Introduction to Cancer Biology (Part 3): Tissue Invasion and Metastasis 29:21 New Advances and Opportunities for Improvement in HR+/HER2- Early Breast Cancer 07:59 What are CDK 4/6 Inhibitors for Breast Cancer? 30:19 Lung Cancer/Tumors 05:54 THRIVING with MBC for 25 Years 47:05 I was told, “You’re stage 4. This is going to kill you." | Abigail’s Metastatic Breast Cancer Story 35:06 Tracy's Story: Metastatic Breast Cancer Thriver 46:31 Adjuvant Therapy | 2023 Best of Breast Conference 28:40 My Cancer Came Back. | Metastatic Breast Cancer | Breast Cancer Journey Part III 05:41 The Finger Test For Hiatal Hernia 08:31 Bree Sandlin: Stage Three Triple-Negative Breast Cancer Patient at MD Anderson 09:47 Advancements in Estrogen Receptor–Positive Breast Cancer 05:55 How to Understand Immunotherapy for Breast Cancer Treatment 04:44 Women with metastatic breast cancer share stories to help others l GMA 07:58 Colorectal Cancer: Recent Changes in the Treatment Landscape 05:58 Metastatic Breast Cancer With Bone-Only Metastases Similar videos 01:08 A Study Investigating Pembrolizumab in Combination With Eribulin in TNBC 00:50 Investigating mechanisms of resistance to CDK4/6 inhibitors 1:15:47 Evolving Landscape of HR-Positive Metastatic Breast Cancer: A Year in Review 01:51 Tucatinib Combination Improved Survival in HER2–Positive Breast Cancer 10:02 Expert Perspectives: CDK 4/6 Inhibitors for ER+ Breast Cancer: Emerging Data and Future Implications 01:14 Endocrine therapy resistance in ER+ metastatic breast cancer 05:01 CDK4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer 02:02 Palbociclib Combined With Fulvestrant in Relapsed Metastatic HR+/HER2- Breast Cancer 40:44 ICAHO19 - Breast cancer session: Sequencing therapies in metastatic breast cancer 03:58 HR+ breast cancer and visceral metastases - video abstract 72592 01:19 MONALEESA-2: improved OS seen in HR+ advanced breast cancer treated with ribociclib + letrozole 04:41 Options for Treatment-Naive Metastatic ER+ Breast Cancer 1:35:31 Leveraging Targeted Therapies to Improve Outcomes Across the Continuum of HER2+ Breast Cancer 51:40 TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal 34:45 Evolving Perspectives on HR-Positive Metastatic Breast Cancer: Current Understanding and New Insi... 34:33 Expert Exchange: Clinical Implications of the Latest Advances in Metastatic Breast Cancer 1:07:43 New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. Schwartzberg More results